These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 8709277

  • 1. Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.
    Litwin V, Nagashima KA, Ryder AM, Chang CH, Carver JM, Olson WC, Alizon M, Hasel KW, Maddon PJ, Allaway GP.
    J Virol; 1996 Sep; 70(9):6437-41. PubMed ID: 8709277
    [Abstract] [Full Text] [Related]

  • 2. Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses.
    Karlsson GB, Gao F, Robinson J, Hahn B, Sodroski J.
    J Virol; 1996 Sep; 70(9):6136-42. PubMed ID: 8709238
    [Abstract] [Full Text] [Related]

  • 3. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM, Berg W, Lewis GK, DeVico AL.
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [Abstract] [Full Text] [Related]

  • 4. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection.
    Freed EO, Martin MA.
    J Biol Chem; 1995 Oct 13; 270(41):23883-6. PubMed ID: 7592573
    [No Abstract] [Full Text] [Related]

  • 5. Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate.
    Verrier FC, Charneau P, Altmeyer R, Laurent S, Borman AM, Girard M.
    Proc Natl Acad Sci U S A; 1997 Aug 19; 94(17):9326-31. PubMed ID: 9256481
    [Abstract] [Full Text] [Related]

  • 6. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B, Peters PJ, Repik A, O'Connell O, Mou Z, Koch M, Somasundaran M, Brody R, Luzuriaga K, Wallace A, Wang S, Lu S, McCauley S, Luban J, Duenas-Decamp M, Gonzalez-Perez MP, Clapham PR.
    J Virol; 2018 Jan 15; 92(2):. PubMed ID: 29118121
    [Abstract] [Full Text] [Related]

  • 7. Generation of lymphocyte cell lines coexpressing CD4 and wild-type or mutant HIV type 1 glycoproteins: implications for HIV type 1 Env-induced cell lysis.
    Krüger U, Pfeiffer T, Bosch V.
    AIDS Res Hum Retroviruses; 1996 Jun 10; 12(9):783-92. PubMed ID: 8738430
    [Abstract] [Full Text] [Related]

  • 8. gp120-independent fusion mediated by the human immunodeficiency virus type 1 gp41 envelope glycoprotein: a reassessment.
    Marcon L, Sodroski J.
    J Virol; 1994 Mar 10; 68(3):1977-82. PubMed ID: 8107258
    [Abstract] [Full Text] [Related]

  • 9. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
    Golding H, Manischewitz J, Vujcic L, Blumenthal R, Dimitrov DS.
    J Virol; 1994 Mar 10; 68(3):1962-9. PubMed ID: 7906314
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human immunodeficiency virus envelope-dependent cell-cell fusion: a quantitative fluorescence cytometric assay.
    Huerta L, Lamoyi E, Báez-Saldaña A, Larralde C.
    Cytometry; 2002 Feb 01; 47(2):100-6. PubMed ID: 11813199
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    Thali M, Furman C, Helseth E, Repke H, Sodroski J.
    J Virol; 1992 Sep 01; 66(9):5516-24. PubMed ID: 1501286
    [Abstract] [Full Text] [Related]

  • 17. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
    Doranz BJ, Baik SS, Doms RW.
    J Virol; 1999 Dec 01; 73(12):10346-58. PubMed ID: 10559353
    [Abstract] [Full Text] [Related]

  • 18. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.
    Alkhatib G, Broder CC, Berger EA.
    J Virol; 1996 Aug 01; 70(8):5487-94. PubMed ID: 8764060
    [Abstract] [Full Text] [Related]

  • 19. Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes.
    Dimitrov DS, Golding H, Blumenthal R.
    AIDS Res Hum Retroviruses; 1991 Oct 01; 7(10):799-805. PubMed ID: 1742075
    [Abstract] [Full Text] [Related]

  • 20. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
    Gallo SA, Puri A, Blumenthal R.
    Biochemistry; 2001 Oct 16; 40(41):12231-6. PubMed ID: 11591141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.